Literature DB >> 23960996

Value of microbiology study in congenital nasolacrimal duct obstruction.

Yasser H Al-Faky1, Tahir Naeem, Nora Al-Sobaie, Reem Al-Huthail, Hessa Al-Odan, Essam A Osman, Ahmad Mousa.   

Abstract

PURPOSE: Evaluation of the effect of different microorganisms on congenital nasolacrimal duct obstruction (CNLDO) tightness and whether probing or silastic intubation is likely to fail in a particular microorganism infection.
METHODS: The culture and sensitivity results of lacrimal drainage system (LDS) discharge samples from patients with CNLDO were reviewed. Different microorganisms were correlated with the severity of nasolacrimal duct (NLD) obstruction observed during surgical intervention. The success rates of probing and silastic intubation as a primary procedure for each identifiable microorganism were documented. Statistical analysis was conducted to correlate the type of microorganism with the tightness of CNLDO and treatment failure.
RESULTS: Out of 181 specimens, 22 had no growth (12.1%). LDS with positive culture had 76.6% successful probing (n = 49) and 82.1% successful silastic intubation (n = 78). Gram-positive and Gram-negative species were almost equally detected. The most prevalent organisms were Streptococcus pneumoniae and Hemophilus influenzae (48.1% and 39.2%, respectively). Tight CNLDO was more prevalent in Serratia marcescens (n = 2; 100%) and Staphylococcus aureus (n = 4; 33.3%) infections with a 7.75 Odds ratio [95% confidence interval (CI), 1.67-34.63]. Staphylococcus aureus had 37.5% successful probing; however, success was achieved in all cases with silastic intubation. Serratia marcescens infections had 100% successful silastic intubation.
CONCLUSION: Microbiology study can predict tight CNLDO and helps in choosing the most successful treatment option. CNLDO with Staphylococcus infection and Serratia marcescens were likely to have tight NLD obstruction and silastic intubation had better outcomes.

Entities:  

Keywords:  Congenital; Microbiology; Nasolacrimal duct; Obstruction

Year:  2012        PMID: 23960996      PMCID: PMC3729323          DOI: 10.1016/j.sjopt.2012.03.001

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


  23 in total

1.  Congenital nasolacrimal duct obstruction: irrigation or probing?

Authors:  Y S Kim; S C Moon; K W Yoo
Journal:  Korean J Ophthalmol       Date:  2000-12

2.  Mitomycin-induced interstitial pneumonitis in a patient with BRCA2 associated metastatic pancreatic carcinoma.

Authors:  Muhammad Wasif Saif; Tong Dai
Journal:  JOP       Date:  2010-05-05

3.  [Identification of bacterial flora of conjunctival sac in congenital nasolacrimal duct obstruction in children].

Authors:  Marek Gerkowicz; Maria Kozioł-Montewka; Małgorzata Pietraś-Trzpiel; Ewa Kosior-Jarecka; Agnieszka Szczepanik; Małgorzata Latalska
Journal:  Klin Oczna       Date:  2005

4.  Dacryocystitis: bacteriological study and its relation with nasal pathology.

Authors:  R N Bale
Journal:  Indian J Ophthalmol       Date:  1987 Jul-Aug       Impact factor: 1.848

5.  Bacteriology and antibiotic therapy in congenital nasolacrimal duct obstruction.

Authors:  A Kuchar; J Lukas; F J Steinkogler
Journal:  Acta Ophthalmol Scand       Date:  2000-12

Review 6.  Clinically suspected primary acquired nasolacrimal duct obstruction: clinicopathologic review of 150 patients.

Authors:  N Tucker; D Chow; F Stockl; F Codère; M Burnier
Journal:  Ophthalmology       Date:  1997-11       Impact factor: 12.079

7.  Stepwise treatment paradigm for congenital nasolacrimal duct obstruction.

Authors:  Douglas R Casady; Dale R Meyer; John W Simon; George O Stasior; Jitka L Zobal-Ratner
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2006 Jul-Aug       Impact factor: 1.746

8.  Staphylococcus aureus protein A activates TNFR1 signaling through conserved IgG binding domains.

Authors:  Marisa I Gómez; Maghnus O'Seaghdha; Mariah Magargee; Timothy J Foster; Alice S Prince
Journal:  J Biol Chem       Date:  2006-05-18       Impact factor: 5.157

9.  Spectrum and the susceptibilities of microbial isolates in cases of congenital nasolacrimal duct obstruction.

Authors:  Kim Usha; Sankaranarayanan Smitha; Nagendra Shah; Prajna Lalitha; Rahul Kelkar
Journal:  J AAPOS       Date:  2006-10       Impact factor: 1.220

10.  Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension.

Authors:  Diana Bonderman; Johannes Jakowitsch; Bassam Redwan; Helga Bergmeister; Maria-Klara Renner; Heidi Panzenböck; Christopher Adlbrecht; Apostolos Georgopoulos; Walter Klepetko; Meinhard Kneussl; Irene M Lang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-31       Impact factor: 8.311

View more
  4 in total

1.  Clinical profile of the patients with pediatric epiphora in a tertiary eye care center.

Authors:  Rebika Dhiman; Bhavna Chawla; Mahesh Chandra; Mandeep S Bajaj; Neelam Pushker
Journal:  Indian J Ophthalmol       Date:  2017-01       Impact factor: 1.848

2.  Assessment of Perinatal Clinical Characteristics, Perinatal Risk Factors, and Microbial Profile in Congenital Nasolacrimal Duct Obstruction in a Tertiary Care Center: A Descriptive Study.

Authors:  Kaviyapriya Natarajan; Nirupama Kasturi; Sujatha Sistla
Journal:  Korean J Ophthalmol       Date:  2022-08-05

3.  A Case-Control Study to Determine the Microbiological Spectrum and Antibiotic Sensitivity Patterns in Congenital Nasolacrimal Duct Obstruction.

Authors:  Muthumeena Muthumalai; Md Shahid Alam; Neha Shrirao; B Mahalakshmi; Bipasha Mukherjee
Journal:  J Curr Ophthalmol       Date:  2022-07-26

4.  Lacrimal sac bacteriology and susceptibility pattern in infants with congenital nasolacrimal duct obstruction in the 1st year of life: a cross-sectional study.

Authors:  Xiao-Yu Zheng; Bonnie Nga Kwan Choy; Ming-Ming Zhou; Cai-Ping Shi; Zheng-Yan Zhao
Journal:  BMC Pediatr       Date:  2020-10-06       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.